MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
20.36
+0.09 (0.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $680.38 million as of December 20, 2024.
Market Cap
680.38M
Enterprise Value
403.53M
1-Year Change
n/a
Ranking
Category
Stock Price
20.36
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $680.38M, an increase of 33.50%. That is a compound annual growth rate of 193.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 680.38M | 33.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 691.58M |
| Evolus | 688.30M |
| Bioventus | 687.67M |
| Keros Therapeutics | 685.39M |
| Dianthus Therapeutics | 681.91M |
| Savara | 676.56M |
| IRADIMED CORPORATION | 676.13M |
| CureVac | 670.70M |